Novo Nordisk A/S - share repurchase programme

Summary by AI BETAClose X

Novo Nordisk is executing a share repurchase programme of up to DKK 15 billion over 12 months from 4 February 2026; under the tranche initiated 6 May 2026 it will repurchase B shares for up to DKK 11,200,000,010.45 in the period 6 May 2026 to 1 February 2027. As of 6 November 2026 the company has repurchased 42,604,179 B shares since 4 February 2026 at an average price of DKK 277.16 per share, equal to DKK 11,808,013,711. Novo Nordisk holds 56,644,876 B shares as treasury stock, representing 1.3% of the 4,465,000,000 total shares.

Disclaimer*

UK 100

Latest directors dealings